News Merck rare tumour drug Ezmekly backed for NHS use Merck's drug for tumours associated with rare disease neurofibromatosis type 1, Ezmekly, has been cleared for NHS use in children as young as two.
News Netcompany claims NHS contract to help digitise screening Denmark's Netcompany has been awarded a five-year, £215m contract from NHS England to build the digital infrastructure for adult screening programmes.
R&D Decarbonising respiratory care requires a new kind of generi... Generics manufacturers have long played a critical role in supporting the sustainability of the NHS, delivering affordable medicines at scale, expanding patient access, and helping healthca
Patients Delivering prevention at scale, PA Consulting’s James Davis James Davis, a healthcare expert at PA Consulting, discusses the digital foundations needed to unlock a prevention first NHS.
Digital Built around the NHS ward: 5 Norwegian healthtech innovators Norwegian healthtech companies are operating inside NHS trusts – tackling everyday problems that shape care.
News UK postcode lottery ends for 'life-changing' cystinosis drug Patients in England with rare disease cystinosis will soon be able to access a drug that has been available in other UK nations for up to three years
News Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer Eli Lilly's imlunestrant (Inluriyo) for breast cancer has received a new FDA approval, in combination with CDK4/6 inhibitor abemaciclib (Verzenio).
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.